Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. - Wikidata - wikimedia - TriplyDB

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.

http://www.wikidata.org/entity/Q45332183

about

Systematic review and meta-analysis of Saccharomyces boulardii in adult patients Treating Clostridium difficile infection with fecal microbiota transplantation Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections WSES guidelines for management of Clostridium difficile infection in surgical patients Clostridium difficile in the ICU: the struggle continues Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review Community-associated Clostridium difficile infection and antibiotics: a meta-analysis The changing epidemiology of Clostridium difficile infections Identification of risk factors for the development of clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections Clostridium difficile extracytoplasmic function σ factor σV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection.Clostridium difficile Infections: What Every Clinician Should Know The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis.Risk Factors for the Development of Clostridium difficile-associated Colitis after Colorectal Cancer Surgery Acid suppression therapy does not predispose to Clostridium difficile infection: the case of the potential bias.Clostridium difficile infection in the community: are proton pump inhibitors to blame?Clostridium difficile infection seasonality: patterns across hemispheres and continents - a systematic review Prevalence and genotypic characteristics of Clostridium difficile in a closed and integrated human and swine population.Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain BI/NAP1/027.Association between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroids Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection.Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.Community-Acquired Clostridium Difficile Infection: Awareness and Clinical Implications Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients.Antibiotic-associated diarrhea: epidemiology, trends and treatment.Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile.Community-acquired Clostridium difficile infection: an increasing public health threat.The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.Emerging therapies for Clostridium difficile infections.Risk factors associated with complications and mortality in patients with Clostridium difficile infection.Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.Clostridium difficile Infection Among Veterans Health Administration Patients.A prospective cohort study on hospital mortality due to Clostridium difficile infection.Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.Incidence and Risk Factors for Community and Hospital Acquisition of Clostridium difficile Infection in the Tel Aviv Sourasky Medical Center.Severe pseudomembranous colitis after moxifloxacin use: a case series.Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient.Clostridium difficile-associated diarrhea in a tertiary care medical center.

P2860

Q24621081-D563E9CA-5B5C-4C7B-A284-5FAD86E87A10 Q24634294-E298D1EE-1889-41B8-89A6-3CC32F881656 Q26752760-5F9CB1E0-6383-4474-BFE6-337A034CF67B Q26795429-877F3A39-22C6-4B9A-9C89-775622784E30 Q26823000-BBF85B00-D1CC-4432-89AE-2AD53691D119 Q26849521-818983B2-EA27-43EA-803C-98653A853ABF Q28073805-A92669AF-6428-4E4D-86AF-ADF33448B8E4 Q28289675-6C5690BA-1B0F-4D05-BBDF-15C346C67014 Q28750385-D44ED879-48E3-44E0-BE6F-54DBE52937CE Q30433267-7295A7D0-2979-49CB-A997-6846DB193D1F Q33603104-7E1B11A5-0BA7-4E91-9834-2918526DF2DD Q34028301-550CFF35-6A5A-4724-BDD9-E0FBA8CE6923 Q34331595-1AF5C0C6-3F46-4510-999E-B2E6EB216647 Q34385353-EA61A36D-8B3E-4D10-A6B2-D39E8C55D0FB Q34400622-C8F45293-B96E-45E1-913F-4599050D01A8 Q35031254-5387E03F-C364-472F-BDAF-31EF0E013978 Q35182396-1F4EBDD5-8579-42B5-A51F-52DA07027297 Q35191338-A0E94604-8B0A-4349-8B90-352D47BCA1D4 Q36438993-B36E1CDA-E0A2-456C-B83C-4289AEAD3F60 Q36510098-08BD479E-24C2-4610-9C61-0D8FC77C2062 Q36683574-21329333-FB83-485C-AE41-69422F9C800A Q36909955-782EAB95-198F-4927-BF19-F8D362C4EB72 Q36961050-5904C4CB-3132-41CE-8ABC-1CC95AD4FF1B Q37190742-715BC148-970D-45D8-BCA6-C653EFE344C8 Q37277087-4560A020-BE9D-4368-A4CC-0BD369B2714D Q37543222-466614D7-394A-4D2D-B55F-8F83299A0F6B Q37655456-C4286B2C-BABA-46D5-9141-2380E962CEAF Q37777151-57CE7AC0-44E3-4491-91D3-31A3C0E0DF3A Q37858531-0A0B5FBD-ECB3-4099-A677-D32608559FCE Q37942841-8F43D487-E23B-4A30-B609-829BC72BF72E Q38004673-40D5EF86-DC07-4C07-A9D7-30228ED77273 Q38661029-B6C095C6-BEA7-4EC5-B2FD-03C84E76D58C Q38880576-8B65C62A-C0F4-4EC2-8D3D-BAAAF1C7BC05 Q38998916-85E639F0-60D5-474A-BD72-A46D7F484B83 Q39587051-1EEA8ECE-8706-4BB8-A53D-9D1E3CE502FE Q40091474-BDDE5BD3-66C0-4A2A-B7D1-0B3B69B8B09C Q40180273-677317E3-A155-4093-8E6E-45FF9FC58C11 Q40402747-9824CBF3-BF05-41DF-85C0-92274A5CC6F9 Q42287895-717A457B-57B0-4BA4-8C92-73BEE32BB09B Q42423715-6469FC74-85AE-4B39-BFC7-3C57FE044D34

P2860

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.

http://www.wikidata.org/entity/Q45332183

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Fluoroquinolone use and risk f ...... nistration health care system.

@en

Fluoroquinolone use and risk f ...... nistration health care system.

@nl

type

label

Fluoroquinolone use and risk f ...... nistration health care system.

@en

Fluoroquinolone use and risk f ...... nistration health care system.

@nl

prefLabel

Fluoroquinolone use and risk f ...... nistration health care system.

@en

Fluoroquinolone use and risk f ...... nistration health care system.

@nl

P1433

Q45332183-10518504-1E36-453C-8D9E-E839DB3EFA0B

P1476

Q45332183-EFEE4B38-D255-4F0C-B97F-13B6F283113A

P2093

Q45332183-055F1A2E-7414-470D-ABEF-1F6775E7E32F

Q45332183-30648A29-0D8B-460D-B5FD-EF14C592156D

Q45332183-C26DD6BC-E9B8-4EB9-96BC-B33F2C1870E9

Q45332183-CA33E3FC-84FE-4A87-8C28-DAB03C8F2994

P2860

Q45332183-00A90BE5-BCC3-41C1-99E8-706C9EDC72F2

Q45332183-0C9D78BF-8CD8-46D8-A6FA-D1453968EFC2

Q45332183-0EBF7BE1-FB44-4629-86F3-1EDF1E353B70

Q45332183-10009543-8B19-45C7-90ED-740B4471F821

Q45332183-159100B8-A4DA-44FB-985C-76D129726D29

Q45332183-300917B8-6BDE-4EC0-9E38-13F89521590F

Q45332183-5380CADE-55D5-41B0-9754-FAE3B9BA2D52

Q45332183-5898F329-2BD3-4366-AF23-0833783FC065

Q45332183-5973C4A2-2031-4D4F-BFCF-98734780D982

Q45332183-61BC65EF-94C3-4F6B-B70B-77A9220C0C1F

P304

Q45332183-DB56F88E-BC9C-4816-BD01-00F196EF2BA7

P31

Q45332183-3ECBECFE-8762-45B9-B2F9-CAA6647951B2

P356

Q45332183-283B510A-A3FC-4AD2-87A0-295ABF0C626A

P407

Q45332183-5E72AD39-AB43-4B03-AC46-6AE11ADB15CB

P433

Q45332183-DA8E0780-3D38-4880-933D-9956B2CEAACC

P478

Q45332183-A33D2E82-3894-439E-B8B4-11B37AC9BB88

P577

Q45332183-CED612FC-2EB1-4B39-9EC7-F0CE6A55B74A

P5875

Q45332183-3FDA5282-5A92-4258-B2FB-63AFEFE161A9

P698

Q45332183-71D49BC7-135F-47E3-8C84-6E38C2D2BDF1

P921

Q45332183-E9635615-9837-443F-90EB-7F918250A41C

P356

P1433

Clinical Infectious Diseases

P1476

Fluoroquinolone use and risk f ...... nistration health care system.

@en

P2093

Gregory J Raugi

http://www.w3.org/2001/XMLSchema#string

Henry W Beneda

http://www.w3.org/2001/XMLSchema#string

Jill E Clarridge

http://www.w3.org/2001/XMLSchema#string

Lynne V McFarland

http://www.w3.org/2001/XMLSchema#string

P2860

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

Data resources in the Department of Veterans Affairs.

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Fluoroquinolone use and Clostridium difficile-associated diarrhea.

Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital.

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?

Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy

Problems with the decontamination of dental handpieces and other intra-oral dental equipment in hospitals.

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

P304

1141-1151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/522187

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5927109

http://www.w3.org/2001/XMLSchema#string

P698

17918075

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile